In this video, Jay B. Wish, MD, professor of clinical medicine at Indiana University School of Medicine and chief medical ...

In this video, Jay B. Wish, MD, professor of clinical medicine at Indiana University School of Medicine and chief medical ...

The Gates Foundation will invest up to $50 million to support Tessera's SCD gene editing treatment, the company said.

Ana Abutog has been a devoted follower of Jesus Nazareno. A housewife from Valenzuela City, she juggles family ...

The sNDA is supported by data from the phase 3 ENERGIZE and ENERGIZE-T studies, which evaluated mitapivat vs placebo in patients with NTD and TD alpha- or beta-thalassemia, respectively.

If approved, AGIO's Pyrukynd will be the first oral therapy for all thalassemia subtypes. A final decision is expected by Sep. 7.

A collaboration between a drug plan and clinical pharmacists led to nearly 50% of members successfully switching to a preferred dipeptidyl-peptidase-4 inhibitor.

The 12-week clinical trial showed significant improvements in glycemic control, evidenced by reduced glycosylated hemoglobin ...

A study published in Cureus has highlighted the high prevalence of anemia among patients with rheumatoid arthritis (RA).

Dr Sunita Tandulwadka was formally installed as the 63rd President of the Federation of Obstetric and Gynaecological ...

Biotech stocks are poised for an exciting 2025 as experts watch for new weight-loss drugs, AI's impact and Trump's second ...

Anemia is prevalent among patients with rheumatoid arthritis, according to study findings published in Cureus.